Sen. Richard Burr (R-NC) said he didn’t include drug accelerated approval reforms in the draft FDA user fee bill he wrote with Senate health committee Chair Patty Murray (D-WA) because he likes the accelerated approval program and FDA did not ask for changes to it. However, the agency did request that Congress reform the program, both in the president’s budget request and at congressional hearings, and the House version of the user fee bill gives FDA more power over accelerated...